Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry Meets With FCC On Medical Body Area Network Spectrum Proposal

This article was originally published in The Gray Sheet

Executive Summary

Two medtech giants took a step closer to creating a new wireless patient monitoring category called medical body area networks – or MBANs – after negotiating how they might peacefully share a band of radiofrequency spectrum with the aerospace industry.

You may also be interested in...



FCC-Appointed Task Force Seeks Public-Private Input In Growing U.S. mHealth Market

An mHealth Task Force appointed by Federal Communications Commission Chairman Julius Genachowski released a draft report Sept. 24 outlining ways federal agencies and private industry can help spur the adoption of mHealth technologies.

Digital Health In Brief

Federal Communications Commission finalizes medical body area network rule. More digital health news.

Medical Body Area Networks Get Go-Ahead From FCC

The Federal Communications Commission voted to approve MBAN spectrum May 24, and is now seeking public comments on how to designate an MBAN coordinator.

Related Content

Latest News
See All
UsernamePublicRestriction

Register

MT029785

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel